Clinical trial
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With…
NCT00347958 · Sanofi Pasteur, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00347958 |
|---|---|
| Title | Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine |
| Official title | Safety Among Adolescents and Adults of Revaccination With Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®) 4 to 5 Years After a Previous Dose |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tetanus, Diphtheria, Pertussis |
| Intervention type | Biological |
| Interventions | Tetanus-diphtheria-acellular pertussis (Tdap) vaccine |
| Enrollment | 545 |
| Start date | Aug 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 4, 2006 |
| Last update posted | Dec 4, 2013 |
| Countries | Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: